John Paulson, Director at Valeant Pharmaceuticals International, Inc. (VRX), sold 1,032,648 shares at $14.40 ($14.9M) on 2017-11-16, disclosed to the SEC on 2017-11-20.
Open-market sale of $14.9M VRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.39 | 344,216 | $5.0M | 33.3% |
| 2 | $14.39 | 344,216 | $5.0M | 33.3% |
| 3 | $14.40 | 344,216 | $5.0M | 33.3% |
| Total | $14.39 avg | 1,032,648 | $14.9M | 100% |
| Filing → |
| BHC | BUY | 2025-06-17 | $42.3M | — | Filing → |
| BHC | BUY | 2025-06-12 | $29.4M | — | Filing → |
| BSIG | BUY | 2020-06-26 | $12.7M | — | Filing → |